鉄過負荷は,哺乳ネズミの乳児のNF-κB誘発性肝炎を活性化する
Lili Qiu1, Xiyu Qin1, Mengxiao Hu1
1College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China.
The Journal of nutritional biochemistry
|February 14, 2026
まとめ
幼児ラットの鉄の過剰摂取は,免疫反応と酸化ストレスを活性化することによって,肝炎と損傷を引き起こしました. この研究は,高レベルの鉄が乳児の肝臓の発達にどのように害を及ぼすかを明らかにしています.
科学分野:
- 小児の栄養について
- 肝臓病理学 肝臓病理学
- 免疫学 免疫学とは
背景:
- 鉄は幼児の発達に不可欠ですが,過度の摂取は,脆弱な新生児の肝臓にリスクをもたらします.
- 乳児における高鉄摂取と肝損傷を結びつける正確なメカニズムは完全に理解されていません.
- 新生児期は肝臓と免疫系の発達にとって重要な時期であり,肝臓が鉄過負荷に敏感になる.
研究 の 目的:
- 乳ネズミの肝臓の構造と機能に対する高鉄補給の影響を調査する.
- 哺乳期における鉄過負荷による肝損傷の原因となる分子メカニズムを解明する.
主な方法:
- 哺乳ネズミは,さまざまなレベルの鉄補給 (10,50,100 mg Fe/kg) を受けた.
- 肝臓の構造,中間代謝,免疫反応を分析した.
- 重要なシグナル伝達経路 (NF-κB,Nrf2/HO-1) と炎症マーカーが評価されました.
主要な成果:
- 高用量の鉄 (50 mg/kg,100 mg/kg) は肝炎を引き起こし,ALTとAST値が上昇した.
- 鉄過負荷はM1マクロファージの偏化を促進し,炎症性サイトカイン (IL-6,TNF-α,IL-1β) を増加させ,NF-κB経路を活性化させた.
- 過剰な鉄は酸化ストレスを誘発し,Nrf2/HO-1抗酸化経路を活性化しますが,この反応は炎症を軽減するのに不十分でした.
結論:
- 哺乳期における過度の鉄の摂取はNF-κB経路を活性化し,M1マクロファージの分極化と炎症を促進し,最終的に肝臓の健康を損なう.
- この研究は,乳児における鉄過負荷による肝損傷のメカニズムを明らかにし,関連疾患の治療のための基礎を提供している.
- 発見は,肝臓の損傷を防ぐために乳児の鉄補給を管理する重要な必要性を強調しています.
関連する概念動画
Inflammation
62.5K
Overview
62.5K
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
282
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
282
Hepatic Portal System
6.4K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.4K
ATP Driven Pumps I: An Overview
10.0K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.0K


